571 related articles for article (PubMed ID: 29253488)
1. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
Williams BG; Gupta S; Wollmers M; Granich R
Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488
[TBL] [Abstract][Full Text] [Related]
2. Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study.
Rautenbach SP; Whittles LK; Meyer-Rath G; Jamieson L; Chidarikire T; Johnson LF; Imai-Eaton JW
Lancet Public Health; 2024 Apr; 9(4):e218-e230. PubMed ID: 38553141
[TBL] [Abstract][Full Text] [Related]
3. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.
Granich RM; Gilks CF; Dye C; De Cock KM; Williams BG
Lancet; 2009 Jan; 373(9657):48-57. PubMed ID: 19038438
[TBL] [Abstract][Full Text] [Related]
4. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
[TBL] [Abstract][Full Text] [Related]
5. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
[TBL] [Abstract][Full Text] [Related]
6. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
7. Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013.
Granich R; Gupta S; Hersh B; Williams B; Montaner J; Young B; Zuniga JM
PLoS One; 2015; 10(7):e0131353. PubMed ID: 26147987
[TBL] [Abstract][Full Text] [Related]
8. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
Johnson LF; May MT; Dorrington RE; Cornell M; Boulle A; Egger M; Davies MA
PLoS Med; 2017 Dec; 14(12):e1002468. PubMed ID: 29232366
[TBL] [Abstract][Full Text] [Related]
9. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
[TBL] [Abstract][Full Text] [Related]
10. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis.
Nanoo A; Izu A; Ismail NA; Ihekweazu C; Abubakar I; Mametja D; Madhi SA
Lancet Infect Dis; 2015 Sep; 15(9):1066-1076. PubMed ID: 26112077
[TBL] [Abstract][Full Text] [Related]
11. Human resources for treating HIV/AIDS: needs, capacities, and gaps.
Bärnighausen T; Bloom DE; Humair S
AIDS Patient Care STDS; 2007 Nov; 21(11):799-812. PubMed ID: 17944556
[TBL] [Abstract][Full Text] [Related]
12. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
[TBL] [Abstract][Full Text] [Related]
13. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
14. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
Gentilini M; Chieze F
Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
[TBL] [Abstract][Full Text] [Related]
15. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
[TBL] [Abstract][Full Text] [Related]
16. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
[TBL] [Abstract][Full Text] [Related]
17. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
Wood E; Braitstein P; Montaner JS; Schechter MT; Tyndall MW; O'Shaughnessy MV; Hogg RS
Lancet; 2000 Jun; 355(9221):2095-100. PubMed ID: 10902622
[TBL] [Abstract][Full Text] [Related]
18. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF
Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587
[TBL] [Abstract][Full Text] [Related]
19. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
[TBL] [Abstract][Full Text] [Related]
20. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.
Walensky RP; Borre ED; Bekker LG; Resch SC; Hyle EP; Wood R; Weinstein MC; Ciaranello AL; Freedberg KA; Paltiel AD
Ann Intern Med; 2016 Sep; 165(5):325-33. PubMed ID: 27240120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
